Clinical trial Recruiting at 1 site Interventional Ages 18 to 38 Women only

Surgery first versus IVF-first for people with advanced endometriosis

Official title: First Line Surgery or First Line Fertility Treatment Using Assisted Reproductive Technologies in Patients With Advanced Endometriosis: A National Multicenter Randomized-controlled Trial

Run by Karolinska Institutet · NCT07240363 · Data updated 2026-11-12

This trial will test whether having surgery before assisted reproductive technologies (like IVF) or going straight to IVF gives people with advanced endometriosis a better chance of pregnancy and live birth.

Quick facts

Study typeInterventional
Ages18 Years to 38 Years
SexWomen only
Enrollment350 (estimated)
SponsorKarolinska Institutet
Academic / other
Locations4 sites (Stockholm, Stockholm County and 3 other locations)
StatusRecruiting
StartedOctober 6, 2025
Main results expectedSeptember 22, 2028
Study endsSeptember 22, 2031
Registry record updatedNovember 20, 2025
Trial IDNCT07240363 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 18–38 with AAGL stage III–IV endometriosis, BMI 18–35, referred or eligible for ART, who have not had prior endometriosis surgery beyond diagnostic laparoscopy or prior IVF/ICSI and who can give informed consent.

Probably not a fit

Patients with prior endometriosis surgery or prior IVF, hydrosalpinx, clear urgent surgical indications, suspected malignancy, large fibroids, or significant uterine malformations are unlikely to benefit or are ineligible for this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional trial compares two first-line approaches for people with advanced (AAGL stage III–IV) endometriosis who want fertility treatment: surgical removal of endometriosis lesions prior to assisted reproductive technologies (ART) versus proceeding directly to ART (for example IVF/ICSI). Eligible participants (age 18–38, BMI 18–35, no prior endometriosis surgery beyond diagnostic laparoscopy, and no prior IVF/ICSI cycles) will be assigned to either surgery followed by ART or to immediate ART and followed for pregnancy and live birth outcomes. Major exclusions include hydrosalpinx, clear indications for immediate surgery, suspected malignancy, large or certain fibroids, and uterine malformations. The study will use reproductive outcomes such as clinical pregnancy and live birth rates to determine whether pre-ART surgery improves chances of having a child compared with ART alone.

Why it matters

Potential benefit: If successful, the trial could clarify whether surgery before ART increases pregnancy and live birth rates and thus guide the best first-line approach for people with advanced endometriosis and infertility.

How similar studies have gone: A small number of observational studies and one meta-analysis have suggested that surgery before IVF may improve pregnancy and live birth rates, but randomized evidence is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 - 38 years old
* Endometriosis AAGL stage III-IV
* Referred or eligible for ART-treatment such as IVF or ICSI, independent of infertility diagnosis (28) (including sperm donation cycles for social reasons) and/or infertility due to dyspareunia/dysmenorrhea caused by endometriosis
* Body mass index 18-35 kg/m2
* Patients who have signed an approved Informed Consent

Exclusion Criteria:

* Previous surgery for endometriosis except diagnostic laparoscopy.
* Previous IVF/ICSI-cycles (including prior fertility preservation cycles)
* Hemato- and/or hydrosalpinx
* Clear indication for surgery such as ureteral stenosis or intestinal sub-occlusive symptoms
* Suspicion of malignancy
* Submucosal fibroids (The International Federation of Gynecology and Obstetrics (FIGO) 0-1, any size) or intramural fibroids (FIGO 2-5, \> 4 cm largest diameter of the largest myoma) (29)
* Uterine malformations (class U1-U6 according to ESHRE/ESGE-classification) (30)
* Patients with contraindications to surgery
* Patients undergoing ART with donated oocytes

Where it's running

  • Sodersjukhuset
    Stockholm, Stockholm County, Sweden
    Recruiting
  • Sahlgrenska University Hospital
    Gothenburg, Västra Götaland County, Sweden
    Not yet recruiting
  • Skåne university hospital, Malmö
    Malmö, Sweden
    Not yet recruiting
  • Uppsala University Hospital, Uppsala
    Uppsala, Sweden
    Not yet recruiting

Study contacts

  • Principal investigator: Malin Brunes, MD, PhD — Karolinska Institutet

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.